These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11277498)

  • 1. Insights into peptide and protein function: a convergent approach.
    Roques BP
    J Pept Sci; 2001 Feb; 7(2):63-73. PubMed ID: 11277498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide interactions with G-protein coupled receptors.
    Marshall GR
    Biopolymers; 2001; 60(3):246-77. PubMed ID: 11774230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of double-stranded RNA by proteins and small molecules.
    Carlson CB; Stephens OM; Beal PA
    Biopolymers; 2003 Sep; 70(1):86-102. PubMed ID: 12925995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
    Shiraki T; Kodama TS; Jingami H; Kamiya N
    Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
    Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
    J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chemical strategy to promote helical peptide-protein interactions involved in apoptosis.
    Liu D; Yang B; Cao R; Huang Z
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4467-9. PubMed ID: 16137879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of modified peptides, potent inhibitors of the xWNT8 and hWNT8 proteins.
    Voronkov AE; Baskin II; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2008 Apr; 26(7):1179-87. PubMed ID: 18296089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of function of a small peptide by a protein.
    Tanaka F; Fuller R
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4059-62. PubMed ID: 16723228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The solution structure of pGolemi, a high affinity Mena EVH1 binding miniature protein, suggests explanations for paralog-specific binding to Ena/VASP homology (EVH) 1 domains.
    Link NM; Hunke C; Mueller JW; Eichler J; Bayer P
    Biol Chem; 2009; 390(5-6):417-26. PubMed ID: 19284291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide/protein hybrid materials: enhanced control of structure and improved performance through conjugation of biological and synthetic polymers.
    Vandermeulen GW; Klok HA
    Macromol Biosci; 2004 Apr; 4(4):383-98. PubMed ID: 15468229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions.
    Zhou GP; Troy FA
    Glycobiology; 2003 Feb; 13(2):51-71. PubMed ID: 12626407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computational approach toward label-free protein quantification using predicted peptide detectability.
    Tang H; Arnold RJ; Alves P; Xun Z; Clemmer DE; Novotny MV; Reilly JP; Radivojac P
    Bioinformatics; 2006 Jul; 22(14):e481-8. PubMed ID: 16873510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative binding modes of proline-rich peptides binding to the GYF domain.
    Gu W; Kofler M; Antes I; Freund C; Helms V
    Biochemistry; 2005 May; 44(17):6404-15. PubMed ID: 15850374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model peptides mimic the structure and function of the N-terminus of the pore-forming toxin sticholysin II.
    Casallanovo F; de Oliveira FJ; de Souza FC; Ros U; Martínez Y; Pentón D; Tejuca M; Martínez D; Pazos F; Pertinhez TA; Spisni A; Cilli EM; Lanio ME; Alvarez C; Schreier S
    Biopolymers; 2006; 84(2):169-80. PubMed ID: 16170802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution structural analysis of mammalian profilin 2a complex formation with two physiological ligands: the formin homology 1 domain of mDia1 and the proline-rich domain of VASP.
    Kursula P; Kursula I; Massimi M; Song YH; Downer J; Stanley WA; Witke W; Wilmanns M
    J Mol Biol; 2008 Jan; 375(1):270-90. PubMed ID: 18001770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins.
    Hetényi C; Paragi G; Maran U; Timár Z; Karelson M; Penke B
    J Am Chem Soc; 2006 Feb; 128(4):1233-9. PubMed ID: 16433540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exact sequence analysis for three-dimensional hydrophobic-polar lattice proteins.
    Schiemann R; Bachmann M; Janke W
    J Chem Phys; 2005 Mar; 122(11):114705. PubMed ID: 15836241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.